Pharmaceutical products

Tender description

NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1 July 2020 for a period of 24 months until 30 June 2022, with options to extend up to a maximum period of 24 months. Please refer to the invitation to offer documents for the list of purchasing points. NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1 July 2020 for a period of 24 months until 30 June 2022, with options to extend up to a maximum period of 24 months. NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1 July 2020 for a period of 24 months until 30 June 2022, with options to extend up to a maximum period of 24 months. NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1 July 2020 for a period of 24 months until 30 June 2022, with options to extend up to a maximum period of 24 months. NHS national framework agreement for the supply of products for the treatment of Haemophilia A. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1 July 2020 for a period of 24 months until 30 June 2022, with options to extend up to a maximum period of 24 months.